This content is intended for use by healthcare professionals.
This Global website is not intended to represent or suggest that particular products are approved or authorized in any particular jurisdiction. You should not construe anything on this website as a promotion or solicitation for any product or service, or as suggesting that a product or service be used where it is not approved or authorized by applicable law and regulation in a particular country, territory, or jurisdiction. To learn which products are approved or authorized in particular countries, please consult the appropriate
*RiaSTAP® is currently only licensed for congenital fibrinogen (factor I) deficiency in the US and Europe.
|Bleeding in acquired factor deficiency of vitamin K-dependent coagulation factors (II, VII, IX, and X) (e.g. Warfarin (Coumadin) reversal and perioperative bleeding; inherited deficiencies of vitamin K-dependent coagulation factors
Beriplex® P/N, Confidex®
||Human prothrombin complex
||Freeze-dried prothrombin complex concentrate (PCC)
|Therapy and prophylaxis of hemorrhagic diatheses in:
Congenital hypo-, dys- or afibrinogenemia
Acquired hypofibrinogenemia resulting from disorders of synthesis in cases of severe liver parenchyma damage, increased intravascular consumption (e.g. as a result of disseminated intravascular coagulation), hyperfibrinolysis, or increased loss
||Freeze-dried fibrinogen (factor I) concentrate